z-logo
open-access-imgOpen Access
Empagliflozin-Metformin Combination Has Antioxidative and Anti-Inflammatory Properties that Correlate with Vascular Protection in Adults with Type 1 Diabetes
Author(s) -
Miodrag Janić,
Matej Cankar,
Jan Šmíd,
Alenka France Štiglic,
Aleš Jerin,
Mišo Šabovič,
Andrej Janež,
Mojca Lunder
Publication year - 2022
Publication title -
journal of diabetes research
Language(s) - English
Resource type - Journals
eISSN - 2314-6753
pISSN - 2314-6745
DOI - 10.1155/2022/6796470
Subject(s) - metformin , empagliflozin , type 2 diabetes , oxidative stress , medicine , glutathione peroxidase , endocrinology , pharmacology , superoxide dismutase , diabetes mellitus

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom